1. Home
  2. PSN vs CYTK Comparison

PSN vs CYTK Comparison

Compare PSN & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Parsons Corporation

PSN

Parsons Corporation

HOLD

Current Price

$64.69

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$70.05

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSN
CYTK
Founded
1944
1997
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
8.3B
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
PSN
CYTK
Price
$64.69
$70.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
17
Target Price
$84.00
$85.59
AVG Volume (30 Days)
1.3M
1.5M
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
3.77
3.49
EPS
2.20
N/A
Revenue
$6,364,245,000.00
$13,368,000.00
Revenue This Year
$6.45
$341.94
Revenue Next Year
$7.69
$48.30
P/E Ratio
$29.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$54.56
$29.31
52 Week High
$89.50
$70.98

Technical Indicators

Market Signals
Indicator
PSN
CYTK
Relative Strength Index (RSI) 45.71 56.80
Support Level $60.45 $59.23
Resistance Level $70.39 $67.75
Average True Range (ATR) 2.27 2.38
MACD -0.15 0.33
Stochastic Oscillator 51.76 79.93

Price Performance

Historical Comparison
PSN
CYTK

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: